Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Birmingham Alabama 35233

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Arizona

Gilbert Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Gilbert Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Phoenix Arizona 85013

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

View More ▼

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

Scottsdale Arizona 85259

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Scottsdale Arizona 85259

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Sun City Arizona 85351

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

Sun City Arizona 85351

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Sun City Arizona 85351

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Tucson Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Tucson Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Tucson Arizona 85724

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

California

Neurosearch-Inc
Torrance California 90505

A Clinical Trial for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients using ADS-5102 (amantadine HCL) Extended Release Capsules

View More ▼

Fountain Valley California 92708

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

Fountain Valley California 92708

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Fountain Valley California 92708

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Fresno California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Fresno California 93710

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Fresno California 93710

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Fresno California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Irvine California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Irvine California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Irvine California 92697

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

La Jolla California 92037

A clinical study for patients with Parkinson's Disease

Loma Linda California 92354

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Loma Linda California 92354

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Long Beach California 90806

A clinical trial seeking patients for a research study for the treatment of Parkinson's Disease

Long Beach California 90806

A Phase 1 clinical study for patients with Parkinson's Disease

Los Angeles California 91403

A clinical study for patients with Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease or Huntington's Disease

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Los Angeles California

Patients are needed to participate in a clinical research study of Various to evaluate Spinal Cord Stimulation, Deep Brain Stimulation, Drug Infusion (Implantable Pumps) or Sacral Nerve Stimulation

Mountain View California 94043

A clinical trial to evaluate treatments for patients with Parkinson's Disease

Napa California

Patients are needed to participate in a clinical research study of Various to evaluate Spinal Cord Stimulation, Deep Brain Stimulation, Drug Infusion (Implantable Pumps) or Sacral Nerve Stimulation

National City California 91950

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Oxnard California 93030

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Pasadena California 91105

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

Pasadena California 91105

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease

Pasadena California 91105

Patients are needed to participate in a clinical research study of Istradefylline 40 mg, Istradefylline 20 mg and Placebo to evaluate Idiopathic Parkinson's Disease

Reseda California 91335

A clinical trial to evaluate treatments using ADS-5102 for patients with Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease (PD)

Reseda California 91335

Patients are needed to participate in a clinical research study of ADS-5102 to evaluate Dyskinesia, Levodopa Induced Dyskinesia (LID) or Parkinson's Disease